nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2C9—brain cancer	0.566	1	CbGaD
Methimazole—CYP2D6—Lomustine—brain cancer	0.065	0.197	CbGbCtD
Methimazole—CYP1A2—Carmustine—brain cancer	0.0643	0.195	CbGbCtD
Methimazole—CYP2D6—Hydroxyurea—brain cancer	0.0492	0.149	CbGbCtD
Methimazole—CYP3A4—Temozolomide—brain cancer	0.0486	0.147	CbGbCtD
Methimazole—CYP3A4—Lomustine—brain cancer	0.0413	0.125	CbGbCtD
Methimazole—CYP2E1—Etoposide—brain cancer	0.0329	0.0997	CbGbCtD
Methimazole—CYP1A2—Etoposide—brain cancer	0.0191	0.0577	CbGbCtD
Methimazole—CYP3A4—Etoposide—brain cancer	0.00998	0.0302	CbGbCtD
Methimazole—Nephritis—Procarbazine—brain cancer	0.0051	0.0953	CcSEcCtD
Methimazole—TPO—Hematopoietic Stem Cell Differentiation—FLI1—brain cancer	0.00507	0.1	CbGpPWpGaD
Methimazole—TPO—Differentiation Pathway—ALK—brain cancer	0.0035	0.0694	CbGpPWpGaD
Methimazole—Pigmentation disorder—Temozolomide—brain cancer	0.00315	0.059	CcSEcCtD
Methimazole—Pigmentation disorder—Etoposide—brain cancer	0.00252	0.0472	CcSEcCtD
Methimazole—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00198	0.0393	CbGpPWpGaD
Methimazole—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.0016	0.0317	CbGpPWpGaD
Methimazole—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00157	0.0311	CbGpPWpGaD
Methimazole—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00156	0.0309	CbGpPWpGaD
Methimazole—TPO—Differentiation Pathway—SHH—brain cancer	0.00146	0.0288	CbGpPWpGaD
Methimazole—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00142	0.0281	CbGpPWpGaD
Methimazole—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.00123	0.0244	CbGpPWpGaD
Methimazole—Alopecia—Lomustine—brain cancer	0.00122	0.0228	CcSEcCtD
Methimazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00122	0.0241	CbGpPWpGaD
Methimazole—TPO—Hematopoietic Stem Cell Differentiation—VAV1—brain cancer	0.00122	0.0241	CbGpPWpGaD
Methimazole—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00121	0.024	CbGpPWpGaD
Methimazole—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00118	0.0234	CbGpPWpGaD
Methimazole—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00111	0.022	CbGpPWpGaD
Methimazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00111	0.0219	CbGpPWpGaD
Methimazole—Leukopenia—Lomustine—brain cancer	0.00107	0.0201	CcSEcCtD
Methimazole—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000993	0.0197	CbGpPWpGaD
Methimazole—Aplastic anaemia—Temozolomide—brain cancer	0.000989	0.0185	CcSEcCtD
Methimazole—Drowsiness—Procarbazine—brain cancer	0.000974	0.0182	CcSEcCtD
Methimazole—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000972	0.0192	CbGpPWpGaD
Methimazole—Thrombocytopenia—Lomustine—brain cancer	0.000958	0.0179	CcSEcCtD
Methimazole—Neuropathy peripheral—Procarbazine—brain cancer	0.000955	0.0179	CcSEcCtD
Methimazole—Jaundice—Procarbazine—brain cancer	0.00095	0.0178	CcSEcCtD
Methimazole—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000935	0.0185	CbGpPWpGaD
Methimazole—Body temperature increased—Carboplatin—brain cancer	0.000884	0.0165	CcSEcCtD
Methimazole—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000845	0.0167	CbGpPWpGaD
Methimazole—Body temperature increased—Lomustine—brain cancer	0.000774	0.0145	CcSEcCtD
Methimazole—Alopecia—Procarbazine—brain cancer	0.000773	0.0145	CcSEcCtD
Methimazole—Drowsiness—Hydroxyurea—brain cancer	0.000754	0.0141	CcSEcCtD
Methimazole—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00075	0.0149	CbGpPWpGaD
Methimazole—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000739	0.0138	CcSEcCtD
Methimazole—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000721	0.0143	CbGpPWpGaD
Methimazole—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.00069	0.0137	CbGpPWpGaD
Methimazole—Leukopenia—Procarbazine—brain cancer	0.000682	0.0127	CcSEcCtD
Methimazole—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000682	0.0135	CbGpPWpGaD
Methimazole—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000664	0.0131	CbGpPWpGaD
Methimazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000649	0.0129	CbGpPWpGaD
Methimazole—Myalgia—Procarbazine—brain cancer	0.000648	0.0121	CcSEcCtD
Methimazole—Arthralgia—Procarbazine—brain cancer	0.000648	0.0121	CcSEcCtD
Methimazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000636	0.0126	CbGpPWpGaD
Methimazole—Vomiting—Lomustine—brain cancer	0.000622	0.0116	CcSEcCtD
Methimazole—Oedema—Procarbazine—brain cancer	0.000621	0.0116	CcSEcCtD
Methimazole—Thrombocytopenia—Procarbazine—brain cancer	0.000608	0.0114	CcSEcCtD
Methimazole—Alopecia—Hydroxyurea—brain cancer	0.000598	0.0112	CcSEcCtD
Methimazole—Neuropathy peripheral—Carmustine—brain cancer	0.000598	0.0112	CcSEcCtD
Methimazole—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000584	0.0116	CbGpPWpGaD
Methimazole—Nausea—Lomustine—brain cancer	0.000581	0.0109	CcSEcCtD
Methimazole—Neuropathy peripheral—Temozolomide—brain cancer	0.000577	0.0108	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000566	0.0106	CcSEcCtD
Methimazole—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000562	0.0111	CbGpPWpGaD
Methimazole—Paraesthesia—Procarbazine—brain cancer	0.000558	0.0104	CcSEcCtD
Methimazole—Somnolence—Procarbazine—brain cancer	0.000552	0.0103	CcSEcCtD
Methimazole—Hepatitis—Temozolomide—brain cancer	0.000529	0.00989	CcSEcCtD
Methimazole—Leukopenia—Hydroxyurea—brain cancer	0.000527	0.00986	CcSEcCtD
Methimazole—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000515	0.0102	CbGpPWpGaD
Methimazole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000511	0.0101	CbGpPWpGaD
Methimazole—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000504	0.00998	CbGpPWpGaD
Methimazole—Urticaria—Procarbazine—brain cancer	0.000494	0.00923	CcSEcCtD
Methimazole—Body temperature increased—Procarbazine—brain cancer	0.000491	0.00919	CcSEcCtD
Methimazole—Alopecia—Carmustine—brain cancer	0.000484	0.00904	CcSEcCtD
Methimazole—Oedema—Hydroxyurea—brain cancer	0.000481	0.00899	CcSEcCtD
Methimazole—Thrombocytopenia—Hydroxyurea—brain cancer	0.000471	0.0088	CcSEcCtD
Methimazole—Alopecia—Temozolomide—brain cancer	0.000467	0.00874	CcSEcCtD
Methimazole—Neuropathy peripheral—Etoposide—brain cancer	0.000462	0.00864	CcSEcCtD
Methimazole—Jaundice—Etoposide—brain cancer	0.000459	0.00859	CcSEcCtD
Methimazole—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000451	0.00893	CbGpPWpGaD
Methimazole—Agranulocytosis—Etoposide—brain cancer	0.00044	0.00823	CcSEcCtD
Methimazole—Pruritus—Procarbazine—brain cancer	0.00044	0.00822	CcSEcCtD
Methimazole—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000434	0.00859	CbGpPWpGaD
Methimazole—Somnolence—Hydroxyurea—brain cancer	0.000428	0.00799	CcSEcCtD
Methimazole—Leukopenia—Carmustine—brain cancer	0.000426	0.00797	CcSEcCtD
Methimazole—Dyspepsia—Hydroxyurea—brain cancer	0.000423	0.00792	CcSEcCtD
Methimazole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000414	0.0082	CbGpPWpGaD
Methimazole—Vertigo—Temozolomide—brain cancer	0.000414	0.00773	CcSEcCtD
Methimazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000412	0.00816	CbGpPWpGaD
Methimazole—Leukopenia—Temozolomide—brain cancer	0.000412	0.0077	CcSEcCtD
Methimazole—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000407	0.00805	CbGpPWpGaD
Methimazole—Myalgia—Carmustine—brain cancer	0.000406	0.00758	CcSEcCtD
Methimazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000404	0.00799	CbGpPWpGaD
Methimazole—TPO—Differentiation Pathway—VEGFA—brain cancer	0.000399	0.0079	CbGpPWpGaD
Methimazole—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000398	0.00789	CbGpPWpGaD
Methimazole—Vomiting—Procarbazine—brain cancer	0.000395	0.00739	CcSEcCtD
Methimazole—Myalgia—Temozolomide—brain cancer	0.000392	0.00733	CcSEcCtD
Methimazole—Arthralgia—Temozolomide—brain cancer	0.000392	0.00733	CcSEcCtD
Methimazole—Rash—Procarbazine—brain cancer	0.000392	0.00733	CcSEcCtD
Methimazole—Dermatitis—Procarbazine—brain cancer	0.000391	0.00732	CcSEcCtD
Methimazole—Headache—Procarbazine—brain cancer	0.000389	0.00728	CcSEcCtD
Methimazole—Oedema—Carmustine—brain cancer	0.000389	0.00727	CcSEcCtD
Methimazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000382	0.00757	CbGpPWpGaD
Methimazole—Thrombocytopenia—Carmustine—brain cancer	0.000381	0.00712	CcSEcCtD
Methimazole—Body temperature increased—Hydroxyurea—brain cancer	0.00038	0.00711	CcSEcCtD
Methimazole—Oedema—Temozolomide—brain cancer	0.000376	0.00703	CcSEcCtD
Methimazole—Alopecia—Etoposide—brain cancer	0.000374	0.00699	CcSEcCtD
Methimazole—Nausea—Procarbazine—brain cancer	0.000369	0.0069	CcSEcCtD
Methimazole—Thrombocytopenia—Temozolomide—brain cancer	0.000368	0.00688	CcSEcCtD
Methimazole—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00036	0.00714	CbGpPWpGaD
Methimazole—Musculoskeletal discomfort—Carmustine—brain cancer	0.000354	0.00662	CcSEcCtD
Methimazole—Paraesthesia—Carmustine—brain cancer	0.000349	0.00653	CcSEcCtD
Methimazole—Somnolence—Carmustine—brain cancer	0.000346	0.00646	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000342	0.0064	CcSEcCtD
Methimazole—Paraesthesia—Temozolomide—brain cancer	0.000337	0.00631	CcSEcCtD
Methimazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000334	0.00662	CbGpPWpGaD
Methimazole—Somnolence—Temozolomide—brain cancer	0.000334	0.00625	CcSEcCtD
Methimazole—Vertigo—Etoposide—brain cancer	0.000331	0.00619	CcSEcCtD
Methimazole—Dyspepsia—Temozolomide—brain cancer	0.000331	0.00618	CcSEcCtD
Methimazole—Leukopenia—Etoposide—brain cancer	0.00033	0.00617	CcSEcCtD
Methimazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000327	0.00648	CbGpPWpGaD
Methimazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000311	0.00617	CbGpPWpGaD
Methimazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00031	0.00613	CbGpPWpGaD
Methimazole—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000307	0.00609	CbGpPWpGaD
Methimazole—Body temperature increased—Carmustine—brain cancer	0.000307	0.00575	CcSEcCtD
Methimazole—Vomiting—Hydroxyurea—brain cancer	0.000306	0.00572	CcSEcCtD
Methimazole—Rash—Hydroxyurea—brain cancer	0.000303	0.00567	CcSEcCtD
Methimazole—Dermatitis—Hydroxyurea—brain cancer	0.000303	0.00566	CcSEcCtD
Methimazole—Headache—Hydroxyurea—brain cancer	0.000301	0.00563	CcSEcCtD
Methimazole—Urticaria—Temozolomide—brain cancer	0.000298	0.00558	CcSEcCtD
Methimazole—Body temperature increased—Temozolomide—brain cancer	0.000297	0.00555	CcSEcCtD
Methimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000295	0.00584	CbGpPWpGaD
Methimazole—Thrombocytopenia—Etoposide—brain cancer	0.000294	0.0055	CcSEcCtD
Methimazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000286	0.00567	CbGpPWpGaD
Methimazole—Nausea—Hydroxyurea—brain cancer	0.000286	0.00534	CcSEcCtD
Methimazole—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000283	0.0056	CbGpPWpGaD
Methimazole—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000281	0.00556	CbGpPWpGaD
Methimazole—Paraesthesia—Etoposide—brain cancer	0.00027	0.00505	CcSEcCtD
Methimazole—Somnolence—Etoposide—brain cancer	0.000267	0.005	CcSEcCtD
Methimazole—Pruritus—Temozolomide—brain cancer	0.000266	0.00497	CcSEcCtD
Methimazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000253	0.005	CbGpPWpGaD
Methimazole—Vomiting—Carmustine—brain cancer	0.000247	0.00462	CcSEcCtD
Methimazole—Rash—Carmustine—brain cancer	0.000245	0.00458	CcSEcCtD
Methimazole—Dermatitis—Carmustine—brain cancer	0.000245	0.00458	CcSEcCtD
Methimazole—Headache—Carmustine—brain cancer	0.000244	0.00455	CcSEcCtD
Methimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000243	0.00481	CbGpPWpGaD
Methimazole—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00024	0.00474	CbGpPWpGaD
Methimazole—Vomiting—Temozolomide—brain cancer	0.000239	0.00447	CcSEcCtD
Methimazole—Urticaria—Etoposide—brain cancer	0.000239	0.00447	CcSEcCtD
Methimazole—Body temperature increased—Etoposide—brain cancer	0.000238	0.00444	CcSEcCtD
Methimazole—Rash—Temozolomide—brain cancer	0.000237	0.00443	CcSEcCtD
Methimazole—Dermatitis—Temozolomide—brain cancer	0.000237	0.00443	CcSEcCtD
Methimazole—Headache—Temozolomide—brain cancer	0.000235	0.0044	CcSEcCtD
Methimazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000233	0.00462	CbGpPWpGaD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000232	0.0046	CbGpPWpGaD
Methimazole—Nausea—Carmustine—brain cancer	0.000231	0.00432	CcSEcCtD
Methimazole—Nausea—Temozolomide—brain cancer	0.000223	0.00417	CcSEcCtD
Methimazole—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.00022	0.00436	CbGpPWpGaD
Methimazole—Pruritus—Etoposide—brain cancer	0.000213	0.00398	CcSEcCtD
Methimazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000197	0.0039	CbGpPWpGaD
Methimazole—Vomiting—Etoposide—brain cancer	0.000191	0.00357	CcSEcCtD
Methimazole—Rash—Etoposide—brain cancer	0.00019	0.00354	CcSEcCtD
Methimazole—Dermatitis—Etoposide—brain cancer	0.000189	0.00354	CcSEcCtD
Methimazole—Headache—Etoposide—brain cancer	0.000188	0.00352	CcSEcCtD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000187	0.00371	CbGpPWpGaD
Methimazole—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000185	0.00366	CbGpPWpGaD
Methimazole—Nausea—Etoposide—brain cancer	0.000179	0.00334	CcSEcCtD
Methimazole—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000177	0.00351	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000175	0.00347	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000174	0.00344	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000171	0.00339	CbGpPWpGaD
Methimazole—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000159	0.00315	CbGpPWpGaD
Methimazole—TPO—Metabolism—CYP2C9—brain cancer	0.000155	0.00307	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000152	0.00301	CbGpPWpGaD
Methimazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000141	0.00279	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000134	0.00266	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000132	0.00262	CbGpPWpGaD
Methimazole—TPO—Metabolism—BSG—brain cancer	0.000132	0.00261	CbGpPWpGaD
Methimazole—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.00013	0.00256	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000123	0.00244	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000122	0.00241	CbGpPWpGaD
Methimazole—TPO—Metabolism—IDH1—brain cancer	0.000113	0.00225	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000108	0.00213	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000105	0.00207	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000103	0.00204	CbGpPWpGaD
Methimazole—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	9.87e-05	0.00196	CbGpPWpGaD
Methimazole—TPO—Metabolism—ENO2—brain cancer	8.96e-05	0.00177	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—CYP2C9—brain cancer	8.07e-05	0.0016	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	7.95e-05	0.00158	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.22e-05	0.00123	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.6e-05	0.00111	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.15e-05	0.00102	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.76e-05	0.000942	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.38e-05	0.000867	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.28e-05	0.000848	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.28e-05	0.000848	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CG—brain cancer	4.11e-05	0.000814	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.01e-05	0.000795	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.77e-05	0.000746	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP2C9—brain cancer	3.76e-05	0.000745	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.43e-05	0.00068	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—BSG—brain cancer	3.2e-05	0.000633	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP2C9—brain cancer	3.04e-05	0.000601	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP2C9—brain cancer	2.97e-05	0.000589	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.93e-05	0.000581	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—IDH1—brain cancer	2.75e-05	0.000545	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—BSG—brain cancer	2.58e-05	0.000511	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—BSG—brain cancer	2.53e-05	0.000501	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP2C9—brain cancer	2.29e-05	0.000454	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—IDH1—brain cancer	2.22e-05	0.000439	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ENO2—brain cancer	2.17e-05	0.000431	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—IDH1—brain cancer	2.17e-05	0.00043	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP2C9—brain cancer	2.11e-05	0.000418	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—BSG—brain cancer	1.95e-05	0.000386	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—BSG—brain cancer	1.79e-05	0.000355	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2C9—brain cancer	1.79e-05	0.000354	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—BSG—brain cancer	1.78e-05	0.000352	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ENO2—brain cancer	1.75e-05	0.000347	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ENO2—brain cancer	1.72e-05	0.00034	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—IDH1—brain cancer	1.68e-05	0.000332	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—IDH1—brain cancer	1.54e-05	0.000305	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—IDH1—brain cancer	1.53e-05	0.000303	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—BSG—brain cancer	1.52e-05	0.000301	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2C9—brain cancer	1.38e-05	0.000273	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.37e-05	0.00027	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ENO2—brain cancer	1.33e-05	0.000262	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—IDH1—brain cancer	1.31e-05	0.000259	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.25e-05	0.000247	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ENO2—brain cancer	1.22e-05	0.000241	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ENO2—brain cancer	1.21e-05	0.000239	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—BSG—brain cancer	1.17e-05	0.000232	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.06e-05	0.000211	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ENO2—brain cancer	1.03e-05	0.000205	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—IDH1—brain cancer	1.01e-05	0.0002	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CG—brain cancer	9.98e-06	0.000198	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CG—brain cancer	8.05e-06	0.000159	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ENO2—brain cancer	7.97e-06	0.000158	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CG—brain cancer	7.88e-06	0.000156	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CG—brain cancer	6.08e-06	0.00012	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CG—brain cancer	5.59e-06	0.000111	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CG—brain cancer	5.55e-06	0.00011	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CG—brain cancer	4.74e-06	9.38e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CG—brain cancer	3.66e-06	7.24e-05	CbGpPWpGaD
